NSG mouse

Last updated

The NSG mouse (NOD scid gamma mouse) is a brand of immunodeficient laboratory mice, developed and marketed by Jackson Laboratory, which carries the strain NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ. NSG branded mice are among the most immunodeficient described to date. [1] NSG branded mice lack mature T cells, B cells, and natural killer (NK) cells. [2] NSG branded mice are also deficient in multiple cytokine signaling pathways, and they have many defects in innate immunity. [2] [3] The compound immunodeficiencies in NSG branded mice permit the engraftment of a wide range of primary human cells, and enable sophisticated modeling of many areas of human biology and disease. NSG branded mice were developed in the laboratory of Dr. Leonard Shultz at Jackson Laboratory, which owns the NSG trade mark.

Contents

Features of NSG mice

Research applications

Related Research Articles

<span class="mw-page-title-main">Severe combined immunodeficiency</span> Genetic disorder leading to severe impairment of the immune system

Severe combined immunodeficiency (SCID), also known as Swiss-type agammaglobulinemia, is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations. SCID involves defective antibody response due to either direct involvement with B lymphocytes or through improper B lymphocyte activation due to non-functional T-helper cells. Consequently, both "arms" of the adaptive immune system are impaired due to a defect in one of several possible genes. SCID is the most severe form of primary immunodeficiencies, and there are now at least nine different known genes in which mutations lead to a form of SCID. It is also known as the bubble boy disease and bubble baby disease because its victims are extremely vulnerable to infectious diseases and some of them, such as David Vetter, have become famous for living in a sterile environment. SCID is the result of an immune system so highly compromised that it is considered almost absent.

<span class="mw-page-title-main">CD34</span> Cluster of differentiation protocol that identifies cell surface antigens.

CD34 is a transmembrane phosphoglycoprotein protein encoded by the CD34 gene in humans, mice, rats and other species.

<span class="mw-page-title-main">Omenn syndrome</span> Medical condition

Omenn syndrome is an autosomal recessive severe combined immunodeficiency. It is associated with hypomorphic missense mutations in immunologically relevant genes of T-cells such as recombination activating genes, Interleukin-7 receptor-α (IL7Rα), DCLRE1C-Artemis, RMRP-CHH, DNA-Ligase IV, common gamma chain, WHN-FOXN1, ZAP-70 and complete DiGeorge syndrome. It is fatal without treatment.

<span class="mw-page-title-main">Common gamma chain</span> Protein-coding gene in humans

The common gamma chain (γc), also known as interleukin-2 receptor subunit gamma or IL-2RG, is a cytokine receptor sub-unit that is common to the receptor complexes for at least six different interleukin receptors: IL-2, IL-4, IL-7, IL-9, IL-15 and interleukin-21 receptor. The γc glycoprotein is a member of the type I cytokine receptor family expressed on most lymphocyte populations, and its gene is found on the X-chromosome of mammals.

<span class="mw-page-title-main">Interleukin 7</span> Growth factor secreted by stromal cells in the bone marrow and thymus.

Interleukin 7 (IL-7) is a protein that in humans is encoded by the IL7 gene.

<span class="mw-page-title-main">X-linked severe combined immunodeficiency</span> Medical condition

X-linked severe combined immunodeficiency (X-SCID) is an immunodeficiency disorder in which the body produces very few T cells and NK cells.

Non-obese diabetic or NOD mice, like biobreeding rats, are used as an animal model for type 1 diabetes. Diabetes develops in NOD mice as a result of insulitis, a leukocytic infiltrate of the pancreatic islets. The onset of diabetes is associated with a moderate glycosuria and a non-fasting hyperglycemia. It is recommended to monitor for development of glycosuria from 10 weeks of age; this can be carried out using urine glucose dipsticks. NOD mice will develop spontaneous diabetes when left in a sterile environment. The incidence of spontaneous diabetes in the NOD mouse is 60–80% in females and 20–30% in males. Onset of diabetes also varies between males and females: commonly, onset is delayed in males by several weeks. The mice are known to carry IgG2c allele.

<span class="mw-page-title-main">CXCL2</span> Mammalian protein found in Homo sapiens

Chemokine ligand 2 (CXCL2) is a small cytokine belonging to the CXC chemokine family that is also called macrophage inflammatory protein 2-alpha (MIP2-alpha), Growth-regulated protein beta (Gro-beta) and Gro oncogene-2 (Gro-2). CXCL2 is 90% identical in amino acid sequence as a related chemokine, CXCL1. This chemokine is secreted by monocytes and macrophages and is chemotactic for polymorphonuclear leukocytes and hematopoietic stem cells. The gene for CXCL2 is located on human chromosome 4 in a cluster of other CXC chemokines. CXCL2 mobilizes cells by interacting with a cell surface chemokine receptor called CXCR2.

<span class="mw-page-title-main">Janus kinase 3</span> Mammalian protein found in Homo sapiens

Tyrosine-protein kinase JAK3 is a tyrosine kinase enzyme that in humans is encoded by the JAK3 gene.

The severe combined immunodeficiency (SCID) is a severe immunodeficiency genetic disorder that is characterized by the complete inability of the adaptive immune system to mount, coordinate, and sustain an appropriate immune response, usually due to absent or atypical T and B lymphocytes. In humans, SCID is colloquially known as "bubble boy" disease, as victims may require complete clinical isolation to prevent lethal infection from environmental microbes.

<span class="mw-page-title-main">Signal-regulatory protein alpha</span> Protein-coding gene in the species Homo sapiens

Signal regulatory protein α (SIRPα) is a regulatory membrane glycoprotein from SIRP family expressed mainly by myeloid cells and also by stem cells or neurons.

<span class="mw-page-title-main">DNA polymerase mu</span> Protein-coding gene

DNA polymerase mu is a polymerase enzyme found in eukaryotes. In humans, this protein is encoded by the POLM gene.

A NOG (NOD/Shi-scid/IL-2Rγnull) mouse is a new generation of severely immunodeficient mouse, developed by Central Institute for Experimental Animals (CIEA) in 2000. The NOG mouse accepts heterologous cells much more easily compared with any other type of immunodeficient rodent models, such as nude mouse and NOD/scid mouse. Thus, the mouse can be the best model as a highly efficient recipient of human cells to engraft, proliferate and differentiate. This unique feature offers a great opportunity for enhancing therapy researches of cancer, leukemia, visceral diseases, AIDS, and other human diseases. It also provides applications for cancer, infection, regeneration, and hematology researches.

A humanized mouse is a genetically modified mouse that has functioning human genes, cells, tissues and/or organs. Humanized mice are commonly used as small animal models in biological and medical research for human therapeutics.

JAK3 deficiency is a dysfunction in cytokine receptor signalling and their production of cytokines.

<span class="mw-page-title-main">IRGs</span>

Immunity Related Guanosine Triphosphatases or IRGs are proteins activated as part of an early immune response. IRGs have been described in various mammals but are most well characterized in mice. IRG activation in most cases is induced by an immune response and leads to clearance of certain pathogens.

Many human blood cells, such as red blood cells (RBCs), immune cells, and even platelets all originate from the same progenitor cell, the hematopoietic stem cell (HSC). As these cells are short-lived, there needs to be a steady turnover of new blood cells and the maintenance of an HSC pool. This is broadly termed hematopoiesis. This event requires a special environment, termed the hematopoietic stem cell niche, which provides the protection and signals necessary to carry out the differentiation of cells from HSC progenitors. This stem-cell niche relocates from the yolk sac to eventually rest in the bone marrow of mammals. Many pathological states can arise from disturbances in this niche environment, highlighting its importance in maintaining hematopoiesis.

Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. It is a form of xenotransplantation. PDX models are used to create an environment that allows for the continued growth of cancer after its removal from a patient. In this way, tumor growth can be monitored in the laboratory, including in response to potential therapeutic options. Cohorts of PDX models can be used to determine the therapeutic efficiency of a therapy against particular types of cancer, or a PDX model from a specific patient can be tested against a range of therapies in a 'personalized oncology' approach.

Mice with severe combined immunodeficiency (SCIDs) are often used in the research of human disease. Human immune cells are used to develop human lymphoid organs within these immunodeficient mice, and many different types of SCID mouse models have been developed. These mice allow researchers to study the human immune system and human disease in a small animal model.

<span class="mw-page-title-main">Mouse Models of Human Cancer database</span> Database of mouse models of human cancer

The laboratory mouse has been instrumental in investigating the genetics of human disease, including cancer, for over 110 years. The laboratory mouse has physiology and genetic characteristics very similar to humans providing powerful models for investigation of the genetic characteristics of disease.

References

  1. ↑ Shultz LD, Ishikawa F, Greiner DL (2007). "Humanized mice in translational biomedical research". Nat. Rev. Immunol. 7 (2): 118–130. doi:10.1038/nri2017. PMID   17259968. S2CID   7933096.
  2. 1 2 3 Shultz LD, Lyons BL, Burzenski LM, et al. (2005). "Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells" (PDF). J. Immunol. 174 (10): 6477–89. doi: 10.4049/jimmunol.174.10.6477 . PMID   15879151.
  3. 1 2 3 4 Shultz LD, Schweitzer PA, Christianson SW, et al. (1995). "Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice". J. Immunol. 154 (1): 180–91. PMID   7995938.
  4. ↑ Takenaka K, Prasolava TK, Wang JC, et al. (2007). "Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells". Nat. Immunol. 8 (12): 1313–23. doi:10.1038/ni1527. PMID   17982459. S2CID   7874854.
  5. 1 2 3 Greiner DL, Hesselton RA, Shultz LD (1998). "SCID mouse models of human stem cell engraftment". Stem Cells. 16 (3): 166–177. doi: 10.1002/stem.160166 . PMID   9617892.
  6. ↑ Blunt T, Finnie NJ, Taccioli GE, et al. (1995). "Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation". Cell. 80 (5): 813–23. doi: 10.1016/0092-8674(95)90360-7 . PMID   7889575.
  7. ↑ Pearson, T; Shultz, LD (2008). "Non-Obese Diabetic-Recombination Activating Gene-1 (NOD- Rag 1 null ) Interleukin (IL)-2 Receptor Common Gamma Chain ( IL 2 Rγ null ) Null Mice: A Radioresistant Model for Human Lymphohaematopoietic Engraftment". Clinical & Experimental Immunology. 154 (2): 270–284. doi:10.1111/j.1365-2249.2008.03753.x. PMC   2612717 . PMID   18785974.
  8. ↑ Fulop, GM; Phillips, RA (1990). "The Scid Mutation in Mice Causes a General Defect in DNA Repair". Nature. 347 (6292): 479–482. Bibcode:1990Natur.347..479F. doi:10.1038/347479a0. PMID   2215662. S2CID   4351206.
  9. 1 2 Cao X, Shores EW, Hu-Li J, et al. (1995). "Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain". Immunity. 2 (3): 223–38. doi: 10.1016/1074-7613(95)90047-0 . PMID   7697543.
  10. ↑ Simpson-Abelson MR, Sonnenberg GF, Takita H, et al. (2008). "Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice". J. Immunol. 180 (10): 7009–18. doi: 10.4049/jimmunol.180.10.7009 . PMID   18453623.
  11. ↑ Escobar G, Moi D, Ranghetti A, et al. (Jan 2014). "Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression". Sci. Transl. Med. 6 (217): 217. doi:10.1126/scitranslmed.3006353. PMID   24382895. S2CID   8430299.
  12. ↑ Eirew P, Stingl J, Raouf A, et al. (2008). "A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability". Nat. Med. 14 (12): 1384–9. doi:10.1038/nm.1791. PMID   19029987. S2CID   205385845.
  13. ↑ Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008). "Efficient tumour formation by single human melanoma cells". Nature. 456 (7222): 593–598. Bibcode:2008Natur.456..593Q. doi:10.1038/nature07567. PMC   2597380 . PMID   19052619.
  14. ↑ Ishikawa F, Yasukawa M, Lyons B, et al. (2005). "Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice". Blood. 106 (5): 1565–73. doi:10.1182/blood-2005-02-0516. PMC   1895228 . PMID   15920010.
  15. ↑ Giassi LJ, Pearson T, Shultz LD, et al. (August 2008). "Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice". Exp. Biol. Med. (Maywood). 233 (8): 997–1012. doi:10.3181/0802-RM-70. PMC   2757278 . PMID   18653783.
  16. ↑ Majeti R, Park CY, Weissman IL (2007). "Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood". Cell Stem Cell. 1 (6): 635–645. doi:10.1016/j.stem.2007.10.001. PMC   2292126 . PMID   18371405.
  17. 1 2 Kumar P, Ban HS, Kim SS, et al. (2008). "T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice". Cell. 134 (4): 577–86. doi:10.1016/j.cell.2008.06.034. PMC   2943428 . PMID   18691745.
  18. ↑ Strowig T, Gurer C, Ploss A, et al. (2009). "Priming of protective T cell responses against virus-induced tumors in mice with human immune system components". J. Exp. Med. 206 (6): 1423–34. doi:10.1084/jem.20081720. PMC   2715061 . PMID   19487422.
  19. ↑ Jiménez-Díaz MB, Mulet T, Viera S, et al. (2009). "Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes". Antimicrob. Agents Chemother. 53 (10): 4533–6. doi:10.1128/AAC.00519-09. PMC   2764183 . PMID   19596869.
  20. ↑ Mota J, Rico-Hesse R (2009). "Humanized mice show clinical signs of dengue fever according to infecting virus genotype". J. Virol. 83 (17): 8638–8645. doi:10.1128/JVI.00581-09. PMC   2738212 . PMID   19535452.
  21. ↑ Jaiswal S, Pearson T, Friberg H, et al. (2009). Unutmaz D (ed.). "Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice". PLOS ONE. 4 (10): e7251. Bibcode:2009PLoSO...4.7251J. doi: 10.1371/journal.pone.0007251 . PMC   2749937 . PMID   19802382.
  22. ↑ King M, Pearson T, Shultz LD, et al. (2008). "A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene". Clin. Immunol. 126 (3): 303–14. doi:10.1016/j.clim.2007.11.001. PMID   18096436.

Notes

1. ^ Mouse Genome Informatics entry for Prkdcscid
2. ^ Mouse Genome Informatics entry for Il2rgtm1Wjl
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.